As the AstraZeneca-Pfizer takeover bid failed, Tim Guilliams, founder and CEO of Accelerate Cambridge startup Healx3, explores the potential of ‘small pharma’.
Read the full article [jbs.cam.ac.uk]
Cambridge Network: Would Pfizer-AstraZeneca mean more ‘Parked-AssetZ’?
As the AstraZeneca-Pfizer takeover bid failed, Tim Guilliams, founder and CEO of Accelerate Cambridge startup Healx3, explores the potential of ‘small pharma’.
Read the full article [jbs.cam.ac.uk]
Comments